SARS-CoV-2 genomics and impact on clinical care for COVID-19 is a research paper published in Journal of Antimicrobial Chemotherapy (2023). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIAID NIH HHS
Grant: U19 AI135964
NCATS NIH HHS
Grant: UL1 TR001422
NCI NIH HHS
Grant: P30 CA060553
NIAID NIH HHS
Grant: R21 AI163912
NCATS NIH HHS
Grant: UL1 TR002389
NIAID NIH HHS
Grant: P30 AI117943
NIAID NIH HHS
Grant: U19 AI171110
National Institutes of Health
Grant: 5R21AI163912-02
Assessing the Risk of SARS-CoV-2 Remdesivir Resistance
National Institutes of Health
Grant: 5UL1TR002389-04
ITM 2.0: Advancing Translational Science in Metropolitan Chicago
National Institutes of Health
Grant: 5P30CA060553-12
The Robert H.Lurie Comprehensive Cancer Center
National Institutes of Health
Grant: 5UL1TR001422-04
Northwestern University Clinical and Translational Science Institute (NUCATS)
National Institutes of Health
Grant: 1U19AI171110-01
QCRG Pandemic Response Program
National Institutes of Health
Grant: 5U19AI135964-02
Successful Clinical Response In Pneumonia Therapy (SCRIPT) Systems Biology Center
National Institutes of Health
Grant: 5P30AI117943-02
Third Coast Center for AIDS Research
NIH
Dixon Family Foundation
FWCI
2.13
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords